423
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Defining and Predicting Opioid and Cocaine Treatment Response

, , &

References

  • Amato, L., Davoli, M., Minozzi, S., Vecchi, S., & Perucci, C. (2006). Should psychosocial intervention be added to pharmacological treatment for opiate abuse/dependence? An overview of systematic reviews of the literature. Italian Journal of Public Health, 3(2), 15–20.
  • Amato, L., Minozzi, S., Davoli, M., Vecchi, S., Ferri, M., & Mayet, S. (2011). Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database of Systematic Reviews. (9), CD005031.
  • Ball, J. C., Lange, W. R., Myers, C. P., & Friedman, S. R. (1988). Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior, 29(3), 214–226. doi: 10.2307/2137033
  • Barthwell, A., Senay, E., Marks, R., & White, R. (1989). Patients successfully maintained with methadone escaped human immunodeficiency virus infection. Archives of General Psychiatry, 46(10), 957–958. doi: 10.1001/archpsyc.1989.01810100099020
  • Belding, M. A., McLellan, A. T., Zanis, D. A., & Incmikoski, R. (1998). Characterizing “nonresponsive” methadone patients. Journal of Substance Abuse Treatment, 15(6), 485–492. doi: 10.1016/S0740-5472(97)00292-4
  • Bell, J., Mattick, R., Hay, A., Chan, J., & Hall, W. (1997). Methadone maintenance and drug-related crime. Journal of Substance Abuse, 9, 15–25.
  • Caplehorn, J., Dalton, M., Cluff, M., & Petrenas, A. (1994). Retention in methadone maintenance and heroin addicts’ risk of death. Addiction, 89(2), 203–207. doi: 10.1111/j.1360-0443.1994.tb00879.x
  • Collins, F., & Varmus, H. (2015). A new initiative on precision medicine. The New England Journal of Medicine, 372(9), 793–795. doi: 10.1056/NEJMp1500523
  • Epstein, D. H., & Preston, K. L. (2010). Daily life hour by hour, with and without cocaine: An ecological momentary assessment study. Psychopharmacology, 211(2), 223–232. doi: 10.1007/s00213-010-1884-x
  • Felson, D. T., Smolen, J. S., Wells, G., Zhang, B., van Tuyl, L. H. D., Funovits, J., … Boers, M. (2011). American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Annals of the Rheumatic Diseases, 70(3), 404–413. doi: 10.1136/ard.2011.149765
  • Gerra, G., Ferri, M., Polidori, E., Santoro, G., Zaimovic, A., & Sternieri, E. (2003). Long-term methadone maintenance effectiveness: Psychosocial and pharmacological variables. Journal of Substance Abuse Treatment, 25(1), 1–8. doi: 10.1016/S0740-5472(03)00031-X
  • Gerstein, D., & Lewin, L. (1990). Treating drug problems. The New England Journal of Medicine, 323(12), 844–848. doi: 10.1056/NEJM199009203231230
  • Goldstein, A., & Herrera, J. (1995). Heroin addicts and methadone treatment in Albuquerque—A 22-year follow-up. Drug and Alcohol Dependence, 40(2), 139–150. doi: 10.1016/0376-8716(95)01205-2
  • Heinz, A. J., Wu, J., Witkiewitz, K., Epstein, D. H., & Preston, K. L. (2009). Marriage and relationship closeness as predictors of cocaine and heroin use. Addictive Behaviors, 34(3), 258–263. doi: 10.1016/j.addbeh.2008.10.020
  • Hillhouse, M., Canamar, C. P., & Ling, W. (2013). Predictors of outcome after short-term stabilization with buprenorphine. Journal of Substance Abuse Treatment, 44(3), 336–342. doi: 10.1016/j.jsat.2012.08.016
  • Hosmer, D.W., & Lemeshow, S. (2000). Model-building strategies and methods for logistic regression: Applied logistic regression (2nd ed., pp. 91–135). New York, NY: Wiley.
  • Kelly, S. M., O’Grady, K. E., Mitchell, S. G., Brown, B. S., & Schwartz, R. P. (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence, 117(2–3), 170–175. doi: 10.1016/j.drugalcdep.2011.01.008
  • Kennedy, A., Phillips, K. A., Epstein, D. H., Reamer, D., Schmittner, J. P., & Preston, K. L. (2013). A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management. Drug and Alcohol Dependence, 130(1–3), 77–84. doi: 10.1016/j.drugalcdep.2012.10.025
  • Kosten, T. R., Rounsaville, B. J., & Kleber, H. D. (1985). Comparison of clinician ratings to self-reports of withdrawal during clonidine detoxification of opiate addicts. American Journal of Drug and Alcohol Abuse, 11(1–2), 1–10. doi: 10.3109/00952998509016845
  • Kowalczyk, W. J., Furnari, M. A., Phillips, K. A., Jobes, M. L., Ghitza, U., Epstein, D. H., & Preston, K. L. (2015). Reducing the cost of free time: Treatment success in a randomized trial of clonidine as adjunct to buprenorphine maintenance is associated with more leisure activities in the clonidine condition. 77th Annual Scientific Meeting of the College on Problems of Drug Dependence, Phoenix, AZ.
  • Lehman, F., Lauzon, P., & Amsel, R. (1993). Methadone maintenance: Predictors of outcome in a Canadian milieu. Journal of Substance Abuse Treatment, 10, 85–89. doi: 10.1016/0740-5472(93)90104-A
  • Magura, S., Staines, G. L., Blankertz, L., & Madison, E. M. (2004). The effectiveness of vocational services for substance users in treatment. Substance Use & Misuse, 39(13–14), 2165–2213. doi: 10.1081/JA-200034589
  • Marlatt, G.A., & Gordon, J.R. (Eds.). (1985). Lapse prevention: Maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press.
  • McLaughlin, K. A., Green, J. G., Gruber, M. J., Sampson, N. A., Zaslavsky, A. M., & Kessler, R. C. (2012). Childhood adversities and first onset of psychiatric disorders in a national sample of US adolescents. Archives of General Psychiatry, 69(11), 1151–1160. doi: 10.1001/archgenpsychiatry.2011.2277
  • McLellan, A. T., Alterman, A. I., Cacciola, J., Metzger, D., & OʼBrien, C. P. (1992). A new measure of substance abuse treatment: Initial studies of the treatment services review. The Journal of Nervous and Mental Disease, 180(2), 101–110. doi: 10.1097/00005053-199202000-00007
  • McLellan, A. T., Arndt, I., Metzger, D., Woody, G., & O’Brien, P. (1993). The effects of psychological services in substance abuse treatment. JAMA: The Journal of the American Medical Association, 269(15), 1953–1959. doi: 10.1001/jama.1993.03500150065028
  • McLellan, A. T., Luborsky, L., Cacciola, J., Griffith, J., Evans, F., Barr, H. L., & OʼBrien, C. P. (1985). New data from the Addiction Severity Index: Reliability and validity in three centers. The Journal of Nervous and Mental Disease, 173(7), 412–423. doi: 10.1097/00005053-198507000-00005
  • Miele, G. M., Carpenter, K. M., Smith Cockerham, M., Trautman, K. D., Blaine, J., & Hasin, D. S. (2000). Substance Dependence Severity Scale (SDSS): Reliability and validity of a clinician-administered interview for DSM-IV substance use disorders. Drug and Alcohol Dependence, 59(1), 63–75.
  • Murphy, S. M., Dweik, D., McPherson, S., & Roll, J. M. (2015). Association between hepatitis C and opioid use while in buprenorphine treatment: Preliminary findings. American Journal of Drug and Alcohol Abuse, 41(1), 88–92. doi: 10.3109/00952990.2014.983274
  • Peirce, J. M., Petry, N. M., Roll, J. M., Kolodner, K., Krasnansky, J., Stabile, P. Q., … Stitzer, M. L. (2009). Correlates of stimulant treatment outcome across treatment modalities. American Journal of Drug and Alcohol Abuse, 35(1), 48–53. doi: 10.1080/00952990802455444
  • Phillips, K. A., Epstein, D. H., Vahabzadeh, M., Mezghanni, M., Lin, J.-L., & Preston, K. L. (2014). Substance use and hepatitis C—An Ecological Momentary Assessment study. Health Psychology, 33(7), 710–719. doi: 10.1037/hea0000087
  • Poling, J., Kosten, T., & Sofuoglu, M. (2007). Treatment outcome predictors for cocaine dependence. American Journal of Drug and Alcohol Abuse, 33(2), 191–206. doi: 10.1080/00952990701199416
  • Preston, K. L., Silverman, K., Higgens, S. T., Brooner, R. K., Montoya, I., Schuster, C. R., & Cone, E. J. (1998). Cocaine use early in treatment predicts outcome in a behavioral treatment program. Journal of Consulting and Clinical Psychology, 66(4), 691–696. doi: 10.1037/0022-006X.66.4.691
  • Robins, L. N., Cottler, L. B., Bucholz, K. K., & Compton, W. M., III. (1995). The Diagnostic Interview Schedule, version IV. St. Louis, MO: Washington University.
  • Roll, J. M., Prendergast, M., Richardson, K., Burdon, W., & Ramirez, A. (2005). Identifying predictors of treatment outcome in a drug court program. American Journal of Drug and Alcohol Abuse, 31(4), 641–656. doi: 10.1081/ADA-200068428
  • Roux, P., Lions, C., Michel, L., Cohen, J., Mora, M., Marcellin, F., … Methaville Study Group, (2014). Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: Implications for clinicians. Current Pharmaceutical Design, 20(25), 4097–4105. doi: 10.2174/13816128113199990623
  • Rowell, T. L., Wu, E., Hart, C. L., Haile, R., & El-Bassel, N. (2012). Predictors of drug use in prison among incarcerated black men. American Journal of Drug and Alcohol Abuse, 38(6), 593–597. doi: 10.3109/00952990.2012.694536
  • Roy, A. (2002). Self-rated childhood emotional neglect and CSF monoamine indices in abstinent cocaine-abusing adults: Possible implications for suicidal behavior. Psychiatry Research, 112(1), 69–75. doi: 10.1016/S0165-1781(02)00176-2
  • Satre, D. D., Chi, F. W., Mertens, J. R., & Weisner, C. M. (2012). Effects of age and life transitions on alcohol and drug treatment outcome over nine years. Journal of Studies on Alcohol and Drugs, 73(3), 459–468. doi: 10.15288/jsad.2012.73.459
  • Sayette, M. A., Shiffman, S., Tiffany, S. T., Niaura, R. S., Martin, C. S., & Schadel, W. G. (2000). The measurement of drug craving. Addiction, 95(8s2), 189–210.
  • Weiss, R. D., Potter, J. S., Fiellin, D. A., Byrne, M., Connery, H. S., Dickinson, W., … Ling, W. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence. Archives of General Psychiatry, 68(12), 1238–1246. doi: 10.1001/archgenpsychiatry.2011.121
  • Weissman, M. M., & Bothwell, S. (1976). Assessment of social adjustment by patient self-report. Archives of General Psychiatry, 33(9), 1111–1115. Sep
  • Willner-Reid, J., Belendiuk, K. A., Schmittner, J. P., Epstein, D. H., & Preston, K. L. (2008). Hepatitis C and HIV risk behaviors in heroin/cocaine users. Journal of Substance Abuse Treatment, 35(1), 78–86. doi: 10.1016/j.jsat.2007.08.011
  • Zachary, R. (1986). Shipley Institute of Living Scale. Revised Manual. Los Angeles, CA: Western Psychological Services.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.